Status:

COMPLETED

PSMA-PET and MRI for Detection of Recurrent Prostate Cancer After Radical Treatment

Lead Sponsor:

Norwegian University of Science and Technology

Collaborating Sponsors:

Haukeland University Hospital

University Hospital of North Norway

Conditions:

Prostatic Neoplasms

Eligibility:

MALE

18+ years

Brief Summary

Approximately one third of prostate cancer patients experience biochemical relapse following initial radical prostatectomy or curative radiotherapy. To determine further treatment, it is of utmost imp...

Eligibility Criteria

Inclusion

  • Inclusion Criteria (surgery cohort):
  • Prostate cancer patients with biochemical relapse in accordance with the European Association of Urology (EAU) guidelines on prostate cancer; two consecutive measurements with PSA ≥ 0.2 ng/ml following radical prostatectomy or PSA \> 2.0 ng/ml above the nadir following definitive radiotherapy
  • Potential candidates for loco-regional pelvic salvage treatment based on age and co-morbidity
  • Exclusion Criteria:
  • Previous salvage therapy for recurrent prostate cancer
  • General contra-indications for an MRI exam (pacemaker, aneurysm clips, any form of metal in the body, or severe claustrophobia)
  • Serious concomitant systemic disorders or reduced cognitive functioning that in the opinion of the investigator would compromise the patient's ability to complete the study or interfere with the evaluation of the efficacy and safety of the study objectives
  • Impaired renal function defined as estimated glomerular filtration rate (eGFR) \< 30 ml/min/1.73 m2
  • Hormonal treatment during the last three months

Exclusion

    Key Trial Info

    Start Date :

    May 1 2020

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    May 1 2023

    Estimated Enrollment :

    300 Patients enrolled

    Trial Details

    Trial ID

    NCT04298112

    Start Date

    May 1 2020

    End Date

    May 1 2023

    Last Update

    November 15 2024

    Active Locations (3)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (3 locations)

    1

    Haukeland University Hospital

    Bergen, Norway

    2

    University Hospital of North Norway

    Tromsø, Norway

    3

    St Olavs Hospital

    Trondheim, Norway

    PSMA-PET and MRI for Detection of Recurrent Prostate Cancer After Radical Treatment | DecenTrialz